AVITA Medical RCEL
NASDAQ RCEL
$15.44 +0.15 (+0.98%)
As of: Oct 22, 2026 · 3:27 PM EDT

AVITA Medical (RCEL) Current Deferred Revenue (2023 - 2024)

Updated

AVITA Medical (RCEL) recorded Current Deferred Revenue of $205,000 in Q2 2024.

Analysis

AVITA Medical (RCEL) Current Deferred Revenue (2023 - 2024) Analysis & Trends

At the end of FY2023, AVITA Medical reported Current Deferred Revenue of $33,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.11 Bn 230.14 Bn 4.88 Bn
2 Abbott Laboratories 177.87 Bn 148.30 Bn 7.27 Bn
3 Danaher 161.52 Bn 145.33 Bn 3.61 Bn
4 Intuitive Surgical 154.56 Bn 134.85 Bn 2.08 Bn
5 Medtronic 122.81 Bn 88.06 Bn 6.34 Bn
6 Stryker 117.32 Bn 103.44 Bn 4.50 Bn
7 Boston Scientific 67.30 Bn 62.07 Bn 3.85 Bn
8 Becton Dickinson 54.67 Bn 51.82 Bn 2.32 Bn
9 Edwards Lifesciences 51.67 Bn 35.68 Bn 1.35 Bn
10 AVITA Medical 472.93 Mn 404.61 Mn 17.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 205,000.00
Dec 31, 2023 33,000.00
API Access

AVITA Medical Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RCEL&period=max&api_key=YOUR_API_KEY